Correlation Between Virpax Pharmaceuticals and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and enGene Holdings Common, you can compare the effects of market volatilities on Virpax Pharmaceuticals and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and EnGene Holdings.
Diversification Opportunities for Virpax Pharmaceuticals and EnGene Holdings
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virpax and EnGene is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and EnGene Holdings go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and EnGene Holdings
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the EnGene Holdings. In addition to that, Virpax Pharmaceuticals is 1.24 times more volatile than enGene Holdings Common. It trades about 0.0 of its total potential returns per unit of risk. enGene Holdings Common is currently generating about 0.04 per unit of volatility. If you would invest 766.00 in enGene Holdings Common on August 26, 2024 and sell it today you would earn a total of 2.00 from holding enGene Holdings Common or generate 0.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. enGene Holdings Common
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| enGene Holdings Common |
Virpax Pharmaceuticals and EnGene Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and EnGene Holdings
The main advantage of trading using opposite Virpax Pharmaceuticals and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| EnGene Holdings vs. Beam Therapeutics | EnGene Holdings vs. Caribou Biosciences | EnGene Holdings vs. Intellia Therapeutics | EnGene Holdings vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |